Skip to main content
Loading
Create Account
Cart
Toggle navigation
Keyword Search
Sign In/Account
Conferences
Toggle
Conference List
Past Meetings
How to Register
Invitation Letter
Submit an Abstract
Poster Display Guidelines
View Abstracts
Cancellations and Transfers
Order an Abstract Booklet
Submit a Conference Concept
Why Participate?
Virtual Keystone Symposia
Financial Aid
Toggle
Student Discounts
Scholarships
Underrepresented Trainee Scholarships
Global Health Travel Awards
Fellows Program
Early-Career Travel Awards
Support Us
Toggle
Donate as a Corporation
Donate as an Individual
Donate as a Foundation
Fund a Fellow
Future of Science Fund
Honor Mentor or Loved One
Current Donors
Gift-in-Kind Media Partners
Contact Development Office
Diversity
Toggle
Career Development Initiatives
Health Disparities Workshops
Fellows Program
Fellows Directory
Underrepresented Trainee Scholarships
Global Health Travel Awards
Early-Career Travel Awards
About
Toggle
Mission and History
Governance
Policies
Contact Us
Join Our Mailing List
Employment Opportunities
Letter From the CEO
Resources
Toggle
Frequently Asked Questions
Attendee Checklist
What to Expect/Bring
Travel Tips and Links
Special Needs
Roommate Bulletin Board
Childcare Bulletin Board
KS Connect App
Loading
This meeting took place in the past. Here is a list of meetings that are related:
There are no records.
Loading
Web Desc
Nucleic Acid Therapeutics: From Base Pairs to Bedsides
Organizer(s): Alan M. Gewirtz (in memoriam), Anastasia Khvorova and Mark A. Kay
Date: January 10 - 15, 2012
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA
Sponsored by Isis Pharmaceuticals, Inc. and Regulus Therapeutics Inc.
For important information on the coronavirus, please
click here
Summary of Meeting:
Small molecules and antibodies have revolutionized the treatment of cancer and appear promising for the treatment of many other diseases as well. Nonetheless, there are many candidate therapeutic targets that are not amenable to attack by the current generation of targeted therapies and, in a small but growing number of patients, resistance to initially successful targeted treatments evolves. This symposium will focus on the medicinal promise of pre- and post- transcriptional gene silencing (PPTGS) using oligodeoxynucleotides, small interfering RNA, microRNA and other nucleic acid based molecules. The meeting is motivated by the hypothesis that these molecules can be developed into effective drugs for the treatment of many common diseases that are collectively responsible for a great deal of human suffering. As this symposium will highlight, there is still much to do, but many in the field now hope that the time has finally arrived when “antisense” therapies will finally come of age and fulfill their promise as the magic bullets of the 21st century.
Scholarship Deadline: September 15 2011
Discounted Abstract Deadline: September 15 2011
Abstract Deadline: October 13 2011
Discounted Registration Deadline: November 10 2011
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Isis Pharmaceuticals, Inc.
Prosensa Therapeutics
Regulus Therapeutics Inc.
RXi Pharmaceuticals
Tekmira
Xavier J. de Mollerat du Jeu
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
Program
Loading
Tuesday, January 10
| 3:00PM - 7:30PM
Registration
Room: Zia Concourse
Tuesday, January 10
| 6:15PM - 7:15PM
Refreshments
Room: Zia Concourse
Tuesday, January 10
| 7:15PM - 8:00PM
Welcome and Introductory Remarks
Room: Anasazi Ballroom
Wednesday, January 11
| 7:00AM - 8:00AM
Breakfast
Room: Eldorado Court
Wednesday, January 11
| 8:00AM - 11:00AM
Basic Mechanisms Underlining Oligonucleotide Therapeutic Dev
elopment
Room: Anasazi Ballroom
Speaker 1 of 6
*
Jennifer A. Doudna
, HHMI/University of California, Berkeley, USA
Wednesday, January 11
| 8:00AM - 11:00AM
Basic Mechanisms Underlining Oligonucleotide Therapeutic Dev
elopment
Room: Anasazi Ballroom
Speaker 2 of 6
Bruce A. Sullenger
, Duke University, USA
Controlling Thrombosis with Aptamers and Inflammation with Their Antidotes
Wednesday, January 11
| 8:00AM - 11:00AM
Basic Mechanisms Underlining Oligonucleotide Therapeutic Dev
elopment
Room: Anasazi Ballroom
Speaker 3 of 6
Robert J. Crouch
, NICHD, National Institutes of Health, USA
Ribonucleases H: Function in Hydrolysis of RNA/DNA Hybrids
Wednesday, January 11
| 8:00AM - 11:00AM
Basic Mechanisms Underlining Oligonucleotide Therapeutic Dev
elopment
Room: Anasazi Ballroom
Speaker 4 of 6
John L. Rinn
, University of Colorado Boulder, USA
Large Intergenic Non-Coding RNAs: From Discovery to Mechanism
Wednesday, January 11
| 8:00AM - 11:00AM
Basic Mechanisms Underlining Oligonucleotide Therapeutic Dev
elopment
Room: Anasazi Ballroom
Speaker 5 of 6
Jin Billy Li
, Stanford University, USA
Generating an Atlas of Mammalian A-to-I RNA Editing
Wednesday, January 11
| 8:00AM - 11:00AM
Basic Mechanisms Underlining Oligonucleotide Therapeutic Dev
elopment
Room: Anasazi Ballroom
Speaker 6 of 6
Dongbo Yu
, University of Texas Southwestern Medical Center, USA
Short Talk: Allele-Selective Inhibition of Huntingtin Expression by Single-Stranded RNAs that Act through the RNAi Pathway
Wednesday, January 11
| 9:20AM - 9:40AM
Coffee Break
Room: Zia Concourse
Wednesday, January 11
| 10:00AM - 10:00AM
On Own for Lunch and Recreation
Wednesday, January 11
| 11:15AM - 1:00PM
Poster Setup
Room: Sunset Room/Eldorado Court
Wednesday, January 11
| 1:00PM - 10:00PM
Poster Viewing
Room: Sunset Room/Eldorado Court
Wednesday, January 11
| 4:30PM - 5:00PM
Coffee Available
Room: Zia Concourse
Wednesday, January 11
| 5:00PM - 7:00PM
Preclinical Developments
Room: Anasazi Ballroom
Speaker 1 of 6
* Bruce A. Sullenger
, Duke University, USA
Wednesday, January 11
| 5:00PM - 7:00PM
Preclinical Developments
Room: Anasazi Ballroom
Speaker 2 of 6
Anastasia Khvorova
, University of Massachusetts Medical School, USA
Asymmetric, Hydrophobically Modified RNAi Compounds: From Mechanism of Action to Clinical Development
Wednesday, January 11
| 5:00PM - 7:00PM
Preclinical Developments
Room: Anasazi Ballroom
Speaker 3 of 6
Ryszard Kole
, Ercole Biotech Consulting, USA
Eteplirsen, an Exon-Skipping Drug Candidate for Treatment of DMD
Wednesday, January 11
| 5:00PM - 7:00PM
Preclinical Developments
Room: Anasazi Ballroom
Speaker 4 of 6
Rasmus O. Bak
, University of Aarhus, Denmark
Short Talk: Variable Potency and Transfer Efficiency of Lentivirus-Encoded miRNA Inhibitors
Wednesday, January 11
| 5:00PM - 7:00PM
Preclinical Developments
Room: Anasazi Ballroom
Speaker 5 of 6
Darren Wong
, Medivation, Inc., USA
Short Talk: Antitumor Efficacy with Dicer Substrate siRNAs in the Absence of Immunostimulatory Effects
Wednesday, January 11
| 5:00PM - 7:00PM
Preclinical Developments
Room: Anasazi Ballroom
Speaker 6 of 6
Anita G. Seto
, Expansion Therapeutics, USA
Short Talk: Discovery and Development of Novel Cardiovascular Drug Candidates Based on microRNA Targeting
Wednesday, January 11
| 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Eldorado Court/Sunset Room
Wednesday, January 11
| 7:30PM - 10:00PM
Poster Session 1
Room: Sunset Room/Eldorado Court
Thursday, January 12
| 7:00AM - 8:00AM
Breakfast
Room: Eldorado Court
Thursday, January 12
| 7:30AM - 8:00AM
Poster Setup
Room: Sunset Room/Eldorado Court
Thursday, January 12
| 8:00AM - 5:00PM
Poster Viewing
Room: Sunset Room/Eldorado Court
Thursday, January 12
| 8:00AM - 11:15AM
Clinical Applications I
Room: Anasazi Ballroom
Speaker 1 of 6
*
Larry Gold
, SomaLogic Inc., USA
Thursday, January 12
| 8:00AM - 11:15AM
Clinical Applications I
Room: Anasazi Ballroom
Speaker 2 of 6
Giles Campion
, Prosensa Therapeutics, Netherlands
Systemic Antisense Treatment for Duchenne Muscular Dystrophy
Thursday, January 12
| 8:00AM - 11:15AM
Clinical Applications I
Room: Anasazi Ballroom
Speaker 3 of 6
Richard S. Geary
, Ionis Pharmaceuticals, Inc., USA
Role of Mipomersen in Potential Treatment of Severe Familial Hypercholesterolemia
Thursday, January 12
| 8:00AM - 11:15AM
Clinical Applications I
Room: Anasazi Ballroom
Speaker 4 of 6
Ian MacLachlan
, Tekmira Pharmaceuticals Corp., Canada
Integrating Preclinical and Clinical Experience in the Development of siRNA Products
Thursday, January 12
| 8:00AM - 11:15AM
Clinical Applications I
Room: Anasazi Ballroom
Speaker 5 of 6
Eli Gilboa
, University of Miami, Miller School of Medicine, USA
Aptamer-Targeted Modulation of Tumor Immunity
Thursday, January 12
| 8:00AM - 11:15AM
Clinical Applications I
Room: Anasazi Ballroom
Speaker 6 of 6
Elena Feinstein
, Quark Pharmaceuticals Inc., Israel
Short Talk: siRNA Therapeutics for Eye Diseases
Thursday, January 12
| 9:20AM - 9:40AM
Coffee Break
Room: Zia Concourse
Thursday, January 12
| 11:15AM - 12:00PM
Lunch
Room: Eldorado Court/Sunset Room
Thursday, January 12
| 12:00PM - 2:30PM
Poster Session 2
Room: Sunset Room/Eldorado Court
Thursday, January 12
| 4:30PM - 5:00PM
Coffee Available
Room: Zia Concourse
Thursday, January 12
| 5:00PM - 5:50PM
Keynote Address
Room: Anasazi Ballroom
Speaker 1 of 2
*
Mark A. Kay
, Stanford University, USA
Thursday, January 12
| 5:00PM - 5:50PM
Keynote Address
Room: Anasazi Ballroom
Speaker 2 of 2
Craig C. Mello
, University of Massachusetts Medical School, USA
RNA World and Therapeutic Applications
Thursday, January 12
| 5:50PM - 7:00PM
Structural Insights: Form Follows Function
Room: Anasazi Ballroom
Speaker 1 of 2
Jennifer A. Doudna
, HHMI/University of California, Berkeley, USA
Dicing and Beyond: Regulatory RNA in Humans and Bacteria
Thursday, January 12
| 5:50PM - 7:00PM
Structural Insights: Form Follows Function
Room: Anasazi Ballroom
Speaker 2 of 2
Remo Rohs
, University of Southern California, USA
DNA Shape is a Source of Protein-DNA Binding Specificity
Thursday, January 12
| 7:00PM - 7:00PM
On Own for Dinner
Friday, January 13
| 7:00AM - 8:00AM
Breakfast
Room: Eldorado Court
Friday, January 13
| 8:00AM - 11:00AM
Novel Technologies in Oligonucleotide Target Discovery
Room: Anasazi Ballroom
Speaker 1 of 6
*
Frank J. Slack
, BIDMC Cancer Center/Harvard Medical School, USA
Friday, January 13
| 8:00AM - 11:00AM
Novel Technologies in Oligonucleotide Target Discovery
Room: Anasazi Ballroom
Speaker 2 of 6
Peter Sarnow
, Stanford University School of Medicine, USA
Masking of the Hepatitis C Viral Genome by miR-122
Friday, January 13
| 8:00AM - 11:00AM
Novel Technologies in Oligonucleotide Target Discovery
Room: Anasazi Ballroom
Speaker 3 of 6
Jonathan S. Weissman
, University of California, San Francisco, USA
Monitoring Protein Synthesis One Codon at a Time through Ribosome Profiling
Friday, January 13
| 8:00AM - 11:00AM
Novel Technologies in Oligonucleotide Target Discovery
Room: Anasazi Ballroom
Speaker 4 of 6
Stephen B. Baylin
, Johns Hopkins University School of Medicine, USA
Methylation Mapping
Friday, January 13
| 8:00AM - 11:00AM
Novel Technologies in Oligonucleotide Target Discovery
Room: Anasazi Ballroom
Speaker 5 of 6
Larry Gold
, SomaLogic Inc., USA
SOMAmers for Diagnostics and Therapeutics
Friday, January 13
| 8:00AM - 11:00AM
Novel Technologies in Oligonucleotide Target Discovery
Room: Anasazi Ballroom
Speaker 6 of 6
Shuo Gu
, Stanford University, USA
Short Talk: Slicing Independent RISC Activation Requires the Argonaute Paz Domain
Friday, January 13
| 9:20AM - 9:40AM
Coffee Break
Room: Zia Concourse
Friday, January 13
| 10:00AM - 10:00AM
On Own for Lunch and Recreation
Friday, January 13
| 4:30PM - 5:00PM
Coffee Available
Room: Zia Concourse
Friday, January 13
| 5:00PM - 7:00PM
Clinical Applications II
Room: Anasazi Ballroom
Speaker 1 of 4
* Peter Sarnow
, Stanford University School of Medicine, USA
Friday, January 13
| 5:00PM - 7:00PM
Clinical Applications II
Room: Anasazi Ballroom
Speaker 2 of 4
Dinah Sah
, Voyager Therapeutics, USA
RNAi Therapeutics in Liver and Neurologic Diseases
Friday, January 13
| 5:00PM - 7:00PM
Clinical Applications II
Room: Anasazi Ballroom
Speaker 3 of 4
Frank J. Slack
, BIDMC Cancer Center/Harvard Medical School, USA
MicroRNA Therapeutics in Cancer
Friday, January 13
| 5:00PM - 7:00PM
Clinical Applications II
Room: Anasazi Ballroom
Speaker 4 of 4
Arthur A. Levin
, Avidity Biosciences, USA
Targeting miR-122 for Treatment of Chronic Hepatitis C Infection with Miravirisen a 15- mer LNA-Modified AntimiR Oligonucleotide: From Bench to Bedside
Friday, January 13
| 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Eldorado Court/Sunset Room
Saturday, January 14
| 7:00AM - 8:00AM
Breakfast
Room: Eldorado Court
Saturday, January 14
| 8:00AM - 11:15AM
Endogenous Small RNAs vs Exogenous Oligos
Room: Anasazi Ballroom
Speaker 1 of 7
* Arthur M. Krieg
, Checkmate Pharmaceuticals, USA
Saturday, January 14
| 8:00AM - 11:15AM
Endogenous Small RNAs vs Exogenous Oligos
Room: Anasazi Ballroom
Speaker 2 of 7
Mark A. Kay
, Stanford University, USA
RISC Loading of Duplex RNAs: Unwinding the Prospects for Antiviral Therapeutics
Saturday, January 14
| 8:00AM - 11:15AM
Endogenous Small RNAs vs Exogenous Oligos
Room: Anasazi Ballroom
Speaker 3 of 7
Christine Esau
, Arcturus Therapeutics, USA
Targeting miR-33 for Atherosclerosis
Saturday, January 14
| 8:00AM - 11:15AM
Endogenous Small RNAs vs Exogenous Oligos
Room: Anasazi Ballroom
Speaker 4 of 7
Muthiah Manoharan
, Alnylam Pharmaceuticals, Inc., USA
“The End of the Beginning:” Evolution of siRNA Conjugates as the Next Generation Systemic Delivery Approach for RNAi Therapeutics
Saturday, January 14
| 8:00AM - 11:15AM
Endogenous Small RNAs vs Exogenous Oligos
Room: Anasazi Ballroom
Speaker 5 of 7
Joshua T. Mendell
, University of Texas Southwestern Medical Center, USA
MicroRNAs in Cancer: Biology and Therapeutic Applications
Saturday, January 14
| 8:00AM - 11:15AM
Endogenous Small RNAs vs Exogenous Oligos
Room: Anasazi Ballroom
Speaker 6 of 7
Ruth Broering
, University Hospital of Essen, Germany
Short Talk: In vivo Application of LNP01-Formulated siRNAs Activates the Hepatic Immune System which can be Controlled by Chemical Ribose Modifications
Saturday, January 14
| 8:00AM - 11:15AM
Endogenous Small RNAs vs Exogenous Oligos
Room: Anasazi Ballroom
Speaker 7 of 7
Christopher J. Cheng
, Yale University, USA
Short Talk: Cell-Penetrating Nanoparticles for Tumor-Targeted OncomiR Inhibition
Saturday, January 14
| 9:00AM - 9:20AM
Coffee Break
Room: Zia Concourse
Saturday, January 14
| 10:00AM - 10:00AM
On Own for Lunch and Recreation
Saturday, January 14
| 4:30PM - 5:00PM
Coffee Available
Room: Zia Concourse
Saturday, January 14
| 5:00PM - 7:15PM
Novel Chemistries, Enhancing Enzymology and Animal Models in
Oligonucleotides Therapeutics Development
Room: Anasazi Ballroom
Speaker 1 of 6
*
Ian MacLachlan
, Tekmira Pharmaceuticals Corp., Canada
Saturday, January 14
| 5:00PM - 7:15PM
Novel Chemistries, Enhancing Enzymology and Animal Models in
Oligonucleotides Therapeutics Development
Room: Anasazi Ballroom
Speaker 2 of 6
Brett P. Monia
, Ionis Pharmaceuticals, Inc., USA
Broadening RNaseH-Based Antisense Pharmacology through Medicinal Chemistry
Saturday, January 14
| 5:00PM - 7:15PM
Novel Chemistries, Enhancing Enzymology and Animal Models in
Oligonucleotides Therapeutics Development
Room: Anasazi Ballroom
Speaker 3 of 6
Allen W. Nicholson
, Temple University, USA
Alternative Mechanisms of Antisense Silencing by 2’-Fluoroarabinose Oligonucleotides
Saturday, January 14
| 5:00PM - 7:15PM
Novel Chemistries, Enhancing Enzymology and Animal Models in
Oligonucleotides Therapeutics Development
Room: Anasazi Ballroom
Speaker 4 of 6
Arthur M. Krieg
, Checkmate Pharmaceuticals, USA
Saturday, January 14
| 5:00PM - 7:15PM
Novel Chemistries, Enhancing Enzymology and Animal Models in
Oligonucleotides Therapeutics Development
Room: Anasazi Ballroom
Speaker 5 of 6
Thazha P. Prakash
, Ionis Pharmaceuticals, Inc., USA
Short Talk: Chemical Approaches for Achieving Activation of RNA Interference with Single Stranded Oligonucleotides in Animals
Saturday, January 14
| 5:00PM - 7:15PM
Novel Chemistries, Enhancing Enzymology and Animal Models in
Oligonucleotides Therapeutics Development
Room: Anasazi Ballroom
Speaker 6 of 6
Marcin T. Kortylewski
, Beckman Research Institute, City of Hope, USA
Short Talk: Two-Pronged Approach to Human Cancer Immunotherapy using CpG-STAT3 siRNA Conjugates
Saturday, January 14
| 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Eldorado Court/Sunset Room
Saturday, January 14
| 8:00PM - 11:00PM
Entertainment
Room: Eldorado Court/Sunset Room
Saturday, January 14
| 8:00PM - 11:00PM
Cash Bar
Room: Eldorado Court/Sunset Room
Sunday, January 15
| 10:23AM - 10:23AM
Departure
*Session Chair
†Invited, not yet responded.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##